Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012–2013 to 2018–2019 Seasons, Quebec, Canada

Author:

Carazo Sara12,Guay Charles-Antoine1234ORCID,Skowronski Danuta M5,Amini Rachid1,Charest Hugues67,De Serres Gaston128,Gilca Rodica128

Affiliation:

1. Biological Risks Unit, Institut National de Santé Publique du Québec , Quebec City, Quebec , Canada

2. Faculty of Medicine, Laval University , Quebec City, Quebec , Canada

3. Pulmonary Hypertension Research Group, Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec , Quebec City, Quebec , Canada

4. Département des Sciences de la Santé Communautaire, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke, Quebec , Canada

5. Communicable Diseases and Immunization Services, British Columbia Centre for Disease Control , Vancouver, British Columbia , Canada

6. Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec , Sainte-Anne-de-Bellevue, Quebec , Canada

7. Faculty of Medicine, Université de Montréal , Montreal, Quebec , Canada

8. Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center , Quebec City, Quebec , Canada

Abstract

Abstract Background Influenza immunization programs aim to reduce the risk and burden of severe outcomes. To inform optimal program strategies, we monitored influenza hospitalizations over 7 seasons, stratified by age, comorbidity, and vaccination status. Methods We assembled data from 4 hospitals involved in an active surveillance network with systematic collection of nasal samples and polymerase chain reaction testing for influenza virus in all patients admitted through the emergency department with acute respiratory infection during the 2012–2013 to 2018–2019 influenza seasons in Quebec, Canada. We estimated seasonal, population-based incidence of influenza-associated hospitalizations by subtype predominance, age, comorbidity, and vaccine status, and derived the number needed to vaccinate to prevent 1 hospitalization per stratum. Results The average seasonal incidence of influenza-associated hospitalization was 89/100 000 (95% confidence interval, 86–93), lower during A(H1N1) (49–82/100 000) than A(H3N2) seasons (73–143/100 000). Overall risk followed a J-shaped age pattern, highest among infants 0–5 months and adults ≥75 years old. Hospitalization risks were highest for children <5 years old during A(H1N1) but for highest adults aged ≥75 years during A(H3N2) seasons. Age-adjusted hospitalization risks were 7-fold higher among individuals with versus without comorbid conditions (214 vs 30/100 000, respectively). The number needed to vaccinate to prevent hospitalization was 82-fold lower for ≥75-years-olds with comorbid conditions (n = 1995), who comprised 39% of all hospitalizations, than for healthy 18–64-year-olds (n = 163 488), who comprised just 6% of all hospitalizations. Conclusions In the context of broad-based influenza immunization programs (targeted or universal), severe outcome risks should be simultaneously examined by subtype, age, comorbidity, and vaccine status. Policymakers require such detail to prioritize promotional efforts and expenditures toward the greatest and most efficient program impact.

Funder

Ministère de la Santé et des Services Sociaux du Québec

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference40 articles.

1. Economic burden of seasonal influenza in the United States;Putri;Vaccine,2018

2. Rates of influenza-associated hospitalization, intensive care unit admission, and in-hospital death by race and ethnicity in the United States from 2009 to 2019;O'Halloran;JAMA Network Open,2021

3. Influenza-related hospitalization and ED visits in children less than 5 years: 2000–2011;Jules;Pediatrics,2015

4. Developing a system to estimate the severity of influenza infection in England: findings from a hospital-based surveillance system between 2010/2011 and 2014/2015;Boddington;Epidemiol Infect,2017

5. Vaccination;Ministère de la Santé et des Services Sociaux Québec,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3